610 Peritoneal carcinomatosis index as a predictor of cytoreductive outcomes in patients with advanced ovarian cancer. (14th December 2020)
- Record Type:
- Journal Article
- Title:
- 610 Peritoneal carcinomatosis index as a predictor of cytoreductive outcomes in patients with advanced ovarian cancer. (14th December 2020)
- Main Title:
- 610 Peritoneal carcinomatosis index as a predictor of cytoreductive outcomes in patients with advanced ovarian cancer
- Authors:
- Yakovleva, Maria
Smirnova, Olga
Ulrikh, Elena
Bakaeva, Elvina
Petrova, Anna
Kozyreva, Ksenia
Shevkunov, Lev
Mikaya, Nikolay
Urmancheeva, Adel
Berlev, Igor - Abstract:
- Abstract : Introduction/Background: In our study, we evaluated the peritoneal carcinomatosis index (PCI) and to study the influence of PCI on the cytoreductive surgery outcomes in patients with advanced ovarian cancer. Methodology: We analyzed the results of 133 patients with serous high-grade ovarian cancer FIGO IIIC-IVB stages. PCI was evaluated at 13 regions (score 0–3 for each region) via pelvic MRI, chest and abdominal CT and staging laparoscopy (S-LPS.) Results: Were performed 23% (31/133) of primary and 77% (102/133) of interval debulking surgery (DS), 68% (90/133) of them were optimal (no residual disease, ODS) and 32% (43/133) were suboptimal (residual tumor of > 1 cm, SDS). The frequency of ODS for PCI 0–15 score was 60–86%, for PCI 15–20 score - 9%, PCI> 20 score – 0%. Preoperative and intraoperative determination of the PCI was equal in 58%. In 19.8% PCI was overestimated during preoperative examination, while the use of laparoscopy evaluated PCI allowed to perform an ODS in these cases. In 21% PCI was underestimated and S-LPS helped to avoid SDS in 89% because of noting a diffuse bowel mesentery involvement. Conclusion: A combination of MRI/CT scans and staging laparoscopy in PCI evaluating is an effective treatment modality which can improve the cytoreductive outcomes in patients with advanced ovarian cancer. Disclosures: No conflict of interest exits in the submission of this study. We confirm that no funding source were used in this study.
- Is Part Of:
- International journal of gynecological cancer. Volume 30(2020)Supplement 4
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 30(2020)Supplement 4
- Issue Display:
- Volume 30, Issue 4, Part 4 (2020)
- Year:
- 2020
- Volume:
- 30
- Issue:
- 4
- Part:
- 4
- Issue Sort Value:
- 2020-0030-0004-0004
- Page Start:
- A128
- Page End:
- A128
- Publication Date:
- 2020-12-14
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2020-ESGO.224 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19776.xml